Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Advanced Research
|
January 9, 2026
METTL4 enhances GLI1 translation through m<sup>6</sup>Am modification to promote tumor progression as a therapeutic target for hepatocellular carcinoma
Weijie Sun, Weiqi Dai, Chaobo Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 30, 2025
FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma
Yan Zhou, Xiaofeng Shen, Shuo Zhang, et al.
Nature Communications
|
January 12, 2022
Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion
Hai Hu, Wentao Shao, Qian Liu, et al.
Hepatology Communications
|
June 4, 2020
Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
Francisco Javier Cubero, Mohamed Ramadan Mohamed, Marius M Woitok, et al.
International Journal of Surgery (London, England)
|
January 8, 2025
Laennec approach for anatomical liver resection assisted by laparoscopy or robotics: a multicenter cohort study
Binghua Li, Dalong Yin, Qifan Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 2020
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
Elisa Manieri, Cintia Folgueira, María Elena Rodríguez, et al.
Cell Death & Disease
|
February 11, 2022
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Hui Ye, Chaobo Chen, Hanghang Wu, et al.
Cancers
|
January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Feifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Cancers
|
January 11, 2022
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Chaobo Chen, Hanghang Wu, Hui Ye, et al.
Hepatology Communications
|
June 18, 2021
An Experimental DUAL Model of Advanced Liver Damage
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Feifei Guo, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Advanced Research
|
January 9, 2026
METTL4 enhances GLI1 translation through m<sup>6</sup>Am modification to promote tumor progression as a therapeutic target for hepatocellular carcinoma
Weijie Sun, Weiqi Dai, Chaobo Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 30, 2025
FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma
Yan Zhou, Xiaofeng Shen, Shuo Zhang, et al.
Nature Communications
|
January 12, 2022
Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion
Hai Hu, Wentao Shao, Qian Liu, et al.
Hepatology Communications
|
June 4, 2020
Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
Francisco Javier Cubero, Mohamed Ramadan Mohamed, Marius M Woitok, et al.
International Journal of Surgery (London, England)
|
January 8, 2025
Laennec approach for anatomical liver resection assisted by laparoscopy or robotics: a multicenter cohort study
Binghua Li, Dalong Yin, Qifan Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 2020
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
Elisa Manieri, Cintia Folgueira, María Elena Rodríguez, et al.
Cell Death & Disease
|
February 11, 2022
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Hui Ye, Chaobo Chen, Hanghang Wu, et al.
Cancers
|
January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Feifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Cancers
|
January 11, 2022
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
Chaobo Chen, Hanghang Wu, Hui Ye, et al.
Hepatology Communications
|
June 18, 2021
An Experimental DUAL Model of Advanced Liver Damage
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Feifei Guo, et al.
Page
of 6